Literature DB >> 10734066

Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion.

V Seghers1, M Nakazaki, F DeMayo, L Aguilar-Bryan, J Bryan.   

Abstract

Sur1 knockout mouse beta-cells lack K(ATP) channels and show spontaneous Ca(2+) action potentials equivalent to those seen in patients with persistent hyperinsulinemic hypoglycemia of infancy, but the mice are normoglycemic unless stressed. Sur1(-/-) islets lack first phase insulin secretion and exhibit an attenuated glucose-stimulated second phase secretion. Loss of the first phase leads to mild glucose intolerance, whereas reduced insulin output is consistent with observed neonatal hyperglycemia. Loss of K(ATP) channels impairs the rate of return to a basal secretory level after a fall in glucose concentration. This leads to increased hypoglycemia upon fasting and contributes to a very early, transient neonatal hypoglycemia. Whereas persistent hyperinsulinemic hypoglycemia of infancy underscores the importance of the K(ATP)-dependent ionic pathway in control of insulin release, the Sur1(-/-) animals provide a novel model for study of K(ATP)-independent pathways that regulate insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734066     DOI: 10.1074/jbc.275.13.9270

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  128 in total

Review 1.  Potassium channels in epithelial transport.

Authors:  Richard Warth
Journal:  Pflugers Arch       Date:  2003-04-18       Impact factor: 3.657

2.  Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels.

Authors:  Christopher J Lynch; Qing Zhou; Show-Ling Shyng; David J Heal; Sharon C Cheetham; Keith Dickinson; Peter Gregory; Michael Firnges; Ulrich Nordheim; Stephanie Goshorn; Dania Reiche; Lechoslaw Turski; Jochen Antel
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

3.  Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations.

Authors:  A Grimberg; R J Ferry; A Kelly; S Koo-McCoy; K Polonsky; B Glaser; M A Permutt; L Aguilar-Bryan; D Stafford; P S Thornton; L Baker; C A Stanley
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

4.  An emerging role for NAADP-mediated Ca2+ signaling in the pancreatic β-cell.

Authors:  Abdelilah Arredouani; A Mark Evans; Jianjie Ma; John Parrington; Michael X Zhu; Antony Galione
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

5.  Characterization of two novel forms of the rat sulphonylurea receptor SUR1A2 and SUR1BDelta31.

Authors:  Laurent Gros; Stefan Trapp; Michael Dabrowski; Frances M Ashcroft; Dominique Bataille; Philippe Blache
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 6.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

Review 7.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 8.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

9.  Energy depletion and not ROS formation is a crucial step of glucolipotoxicity (GLTx) in pancreatic beta cells.

Authors:  Morgana Barroso Oquendo; Nikolas Layer; Rebecca Wagner; Peter Krippeit-Drews; Gisela Drews
Journal:  Pflugers Arch       Date:  2017-12-07       Impact factor: 3.657

10.  Chronic stimulation induces adaptive potassium channel activity that restores calcium oscillations in pancreatic islets in vitro.

Authors:  Nathan C Law; Isabella Marinelli; Richard Bertram; Kathryn L Corbin; Cara Schildmeyer; Craig S Nunemaker
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-02-18       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.